{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:29:27Z","timestamp":1760707767482},"reference-count":131,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.hfc.2006.05.002","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T15:27:03Z","timestamp":1168442823000},"page":"231-247","source":"Crossref","is-referenced-by-count":6,"title":["Novel Imaging Strategies for Predicting Remodeling and Evolution of Heart Failure: Targeting the Renin-angiotensin System"],"prefix":"10.1016","volume":"2","author":[{"given":"Jamshid","family":"Shirani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagat","family":"Narula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Eckelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasken","family":"Dilsizian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.hfc.2006.05.002_bib1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling\u2013concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. On behalf of an International Forum on Cardiac Remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.hfc.2006.05.002_bib2","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/01.CIR.101.25.2981","article-title":"Left ventricular remodeling after myocardial infarction: pathophysiology and therapy","volume":"101","author":"Sutton","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib3","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0735-1097(99)00025-X","article-title":"Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism","volume":"33","author":"Brunner-La Rocca","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00001573-200111000-00002","article-title":"The clinical implication of tissue renin angiotensin system","volume":"6","author":"Re","year":"2001","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/01.CIR.86.2.431","article-title":"Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators","volume":"86","author":"Konstam","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib6","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/01.CIR.88.5.2277","article-title":"Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators","volume":"88","author":"Konstam","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib7","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1161\/01.CIR.91.10.2573","article-title":"Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy","volume":"91","author":"Greenberg","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2006.05.002_bib9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jacc.2005.04.038","article-title":"Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure","volume":"46","author":"Pitt","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.CIR.101.5.558","article-title":"\u03b2-Adrenergic receptor blockade in chronic heart failure","volume":"101","author":"Bristow","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib11","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1056\/NEJM198409273111310","article-title":"The adrenergic nervous system in heart failure","volume":"311","author":"Bristow","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2006.05.002_bib12","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.CIR.100.9.999","article-title":"Mechanisms and models in heart failure: a combinatorial approach","volume":"100","author":"Mann","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib13","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1161\/01.CIR.91.10.2504","article-title":"Structural basis for heart failure: ventricular remodeling and its pharmacological inhibition","volume":"91","author":"Cohn","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0735-1097(89)90504-4","article-title":"Left ventricular shape, afterload, and survival in idiopathic dilated cardiomyopathy","volume":"13","author":"Douglas","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib15","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199705083361903","article-title":"Left ventricular dilation and the risk of congestive heart failure in people without myocardial infarction","volume":"336","author":"Vasan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2006.05.002_bib16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0735-1097(85)80418-6","article-title":"Afterload mismatch in aortic and mitral valve disease: implications for surgical therapy","volume":"5","author":"Ross","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib17","doi-asserted-by":"crossref","first-page":"94E","DOI":"10.1016\/S0002-9149(88)80020-1","article-title":"Reduced subendocardial myocardial perfusion as one mechanism for congestive heart failure","volume":"62","author":"Vatner","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib18","first-page":"H801","article-title":"Impaired regional subendocardial coronary flow reserve in conscious dogs with pacing-induced heart failure","volume":"265","author":"Shannon","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib19","first-page":"H1788","article-title":"Impaired subendocardial function in tachycardia-induced cardiac failure","volume":"268","author":"LeGrice","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jacc.2004.10.030","article-title":"Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction","volume":"45","author":"Grigioni","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib21","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1172\/JCI119770","article-title":"Changes in gene expression in the intact human heart: down-regulation of \u03b1-myosin heavy chain in hypertrophied, failing ventricular myocardium","volume":"100","author":"Lowes","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hfc.2006.05.002_bib22","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1172\/JCI119776","article-title":"Myosin heavy chain gene expression in human heart failure","volume":"100","author":"Nakao","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hfc.2006.05.002_bib23","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.CIR.83.2.504","article-title":"Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy","volume":"83","author":"Schaper","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib24","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/01.CIR.85.3.1046","article-title":"Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure","volume":"85","author":"Beuckelmann","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJM198207223070401","article-title":"Decreased catecholamine sensitivity and \u03b2-adrenergic-receptor density in failing human hearts","volume":"307","author":"Bristow","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2006.05.002_bib26","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.CIR.85.2.790","article-title":"Adrenergic effects on the biology of the adult mammalian cardiocyte","volume":"85","author":"Mann","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib27","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM199610173351603","article-title":"Apoptosis in myocytes in end-stage heart failure","volume":"335","author":"Narula","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2006.05.002_bib28","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJM199704173361603","article-title":"Apoptosis in the failing human heart","volume":"336","author":"Olivetti","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2006.05.002_bib29","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1161\/01.CIR.96.11.4065","article-title":"Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation","volume":"96","author":"Weber","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cvr\/27.3.341","article-title":"Myocardial fibrosis: functional significance and regulatory factors","volume":"27","author":"Weber","year":"1993","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hfc.2006.05.002_bib31","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1161\/01.HYP.23.6.869","article-title":"Structural remodeling in hypertensive heart disease and the role of hormones","volume":"23","author":"Weber","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.hfc.2006.05.002_bib32","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/01.CIR.97.17.1708","article-title":"Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage heart failure","volume":"97","author":"Thomas","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib33","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/01.CIR.98.17.1728","article-title":"Differential expression of tissue inhibitors of metalloproteinases in the failing human heart","volume":"98","author":"Li","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib34","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1172\/JCI117277","article-title":"Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation","volume":"93","author":"Tsutsui","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hfc.2006.05.002_bib35","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1056\/NEJMoa012630","article-title":"Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents","volume":"346","author":"Lowes","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2006.05.002_bib36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJM199108013250502","article-title":"A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure","volume":"325","author":"Cohn","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2006.05.002_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2006.05.002_bib38","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction","volume":"327","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2006.05.002_bib39","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.94.11.2807","article-title":"Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure","volume":"94","author":"Bristow","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib40","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2006.05.002_bib41","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2006.05.002_bib42","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","article-title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme","volume":"362","author":"Pfeffer","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2006.05.002_bib43","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0735-1097(92)90167-L","article-title":"The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure","volume":"20","author":"Packer","year":"1992","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 2","key":"10.1016\/j.hfc.2006.05.002_bib44","first-page":"10","article-title":"The role of renin-angiotensin system in the pathophysiology of cardiac remodeling","volume":"5","author":"Booz","year":"1996","journal-title":"Blood Press"},{"key":"10.1016\/j.hfc.2006.05.002_bib45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1009788013090","article-title":"Actions of angiotensin II on isolated cardiac myocytes","volume":"3","author":"Booz","year":"1998","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.hfc.2006.05.002_bib46","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1006\/jmcc.2002.2077","article-title":"Role of the local renin-angiotensin system in cardiac damage: a minireview focusing on transgenic animal models","volume":"34","author":"Bader","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib47","first-page":"H2337","article-title":"Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide","volume":"281","author":"Berry","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/351233a0","article-title":"Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor","volume":"351","author":"Murphy","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.hfc.2006.05.002_bib49","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/351230a0","article-title":"Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor","volume":"351","author":"Sasaki","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.hfc.2006.05.002_bib50","doi-asserted-by":"crossref","first-page":"24543","DOI":"10.1016\/S0021-9258(19)74499-8","article-title":"Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition","volume":"268","author":"Kambayashi","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hfc.2006.05.002_bib51","doi-asserted-by":"crossref","first-page":"24539","DOI":"10.1016\/S0021-9258(19)74498-6","article-title":"Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors","volume":"268","author":"Mukoyama","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hfc.2006.05.002_bib52","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1006\/jmcc.2002.2077","article-title":"Role of the local renin-angiotensin system in cardiac damage: a minireview focusing on transgenic animal models","volume":"34","author":"Bader","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib53","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI0214276","article-title":"Pivotal role of the renin\/prorenin receptor in angiotensin II production and cellular response to renin","volume":"109","author":"Nguyen","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hfc.2006.05.002_bib54","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/bies.10248","article-title":"The intracrine hypothesis and intracellular peptide hormone action","volume":"25","author":"Re","year":"2003","journal-title":"Bioessays"},{"key":"10.1016\/j.hfc.2006.05.002_bib55","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.35.6.1183","article-title":"Angiotensin II and the heart. On the intracrine renin-angiotensin system","volume":"35","author":"De Mello","year":"2000","journal-title":"Hypertens"},{"key":"10.1016\/j.hfc.2006.05.002_bib56","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1161\/hy0202.103002","article-title":"Prorenin-induced myocyte proliferation. No role for intracellular angiotensin","volume":"39","author":"Saris","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.hfc.2006.05.002_bib57","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.RES.0000019242.51541.99","article-title":"Functional significance of prorenin internalization in the rat heart","volume":"90","author":"Peters","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2006.05.002_bib58","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0008-6363(98)00121-7","article-title":"Angiotensin II stimulates cardiomyocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts","volume":"40","author":"Gray","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hfc.2006.05.002_bib59","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0167-0115(00)00136-1","article-title":"Reactive oxygen species as mediators of angiotensin II signaling","volume":"91","author":"Griendling","year":"2000","journal-title":"Regul Pept"},{"key":"10.1016\/j.hfc.2006.05.002_bib60","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1161\/01.CIR.100.20.2093","article-title":"Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction","volume":"100","author":"Harada","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib61","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/hrt.2003.025312","article-title":"Aldosterone blockade in cardiovascular disease","volume":"90","author":"Struthers","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2006.05.002_bib62","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1006\/jmcc.1999.0963","article-title":"Extra-adrenal mineralocorticoids and cardiovascular tissue","volume":"31","author":"Slight","year":"1999","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib63","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.RES.71.3.503","article-title":"Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor","volume":"71","author":"Lombes","year":"1992","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2006.05.002_bib64","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1172\/JCI117322","article-title":"Increased angiotensin-I converting enzyme gene expression in the failing human heart: quantification by competitive RNA polymerase chain reaction","volume":"94","author":"Studer","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hfc.2006.05.002_bib65","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/01.CIR.96.1.220","article-title":"Prorenin, renin, angiotensin and angiotensin converting enzyme in normal and failing hearts: evidence for renin binding","volume":"96","author":"Danser","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib66","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/hh0901.089882","article-title":"Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function","volume":"88","author":"Neri Serneri","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2006.05.002_bib67","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/01.CIR.91.5.1461","article-title":"Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts","volume":"91","author":"Regitz-Zagrosek","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib68","first-page":"H324","article-title":"Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats","volume":"259","author":"Baker","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib69","first-page":"H2443","article-title":"Hypertrophic growth of cultured neonatal rat heart cells mediated by type 1 angiotensin II receptor","volume":"266","author":"Miyata","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib70","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/01.RES.80.1.139","article-title":"Angiotensin II stimulates c-Jun NH2-terminal kinase in cultured cardiac myocytes of neonatal rats","volume":"80","author":"Kudoh","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2006.05.002_bib71","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/01.RES.81.4.611","article-title":"Role of angiotensin II in activation of the JAK\/STAT pathway induced by acute pressure overload in the rat heart","volume":"81","author":"Pan","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2006.05.002_bib72","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0092-8674(93)90541-W","article-title":"Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro","volume":"75","author":"Sadoshima","year":"1993","journal-title":"Cell"},{"issue":"Suppl III","key":"10.1016\/j.hfc.2006.05.002_bib73","doi-asserted-by":"crossref","first-page":"III-346","DOI":"10.1161\/01.CIR.102.suppl_3.III-346","article-title":"Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker. Implication of bradykinin-dependent and bradykinin-independent mechanisms","volume":"102","author":"Sato","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib74","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1152\/physrev.1999.79.1.215","article-title":"Molecular mechanisms of myocardial remodeling","volume":"79","author":"Swynghedauw","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1016\/j.hfc.2006.05.002_bib75","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1161\/hy1201.099615","article-title":"Cardiomyocyte apoptotic cell death in arterial hypertension: mechanisms and potential management","volume":"38","author":"Fortuno","year":"2001","journal-title":"Hypertens"},{"key":"10.1016\/j.hfc.2006.05.002_bib76","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1586\/14779072.1.2.293","article-title":"Involvement of cardiomyocyte survival-apoptosis balance in hypertensive cardiac remodeling","volume":"1","author":"Fortuno","year":"2003","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.hfc.2006.05.002_bib77","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/00004872-200108000-00015","article-title":"Effects of angiotensin II subtype 1 receptor blockade on cardiac fibrosis and sarcoplasmic reticulum Ca2+ handling in hypertensive transgenic rats overexpressing the Ren2 gene","volume":"19","author":"Rothermund","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.hfc.2006.05.002_bib78","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1006\/jmcc.1994.1098","article-title":"Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone","volume":"26","author":"Brilla","year":"1994","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib79","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/hc0602.104675","article-title":"Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy","volume":"105","author":"Takeda","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib80","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart: role of oxidative stress","volume":"161","author":"Sun","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hfc.2006.05.002_bib81","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.CIR.0000153800.09920.40","article-title":"Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload","volume":"111","author":"Kuster","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib82","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-1-4615-5385-4_4","article-title":"Regulation and role of myocardial collagen matrix remodeling in hypertensive heart disease","volume":"432","author":"Funck","year":"1997","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.hfc.2006.05.002_bib83","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1006\/jmcc.2002.2115","article-title":"Appraisal of the role of angiotensin II and aldosterone in ventricular myocyte apoptosis in adult normotensive rat","volume":"34","author":"De Angelis","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib84","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.CIR.0000051865.66123.B7","article-title":"Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms","volume":"107","author":"Hein","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib85","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.RES.69.1.107","article-title":"Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries","volume":"69","author":"Brilla","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2006.05.002_bib86","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00001573-200007000-00010","article-title":"Fibrosis and hypertensive heart disease","volume":"15","author":"Weber","year":"2000","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib87","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.CIR.103.1.155","article-title":"Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction","volume":"103","author":"Woodiwiss","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib88","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/01.CIR.0000125741.88712.77","article-title":"Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of angiotensin-converting enzyme inhibitor","volume":"109","author":"Sakata","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib89","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.jhh.1001012","article-title":"Working under pressure: the vascular endothelium in arterial hypertension","volume":"14","author":"Spieker","year":"2000","journal-title":"J Hum Hypertens"},{"issue":"Suppl 1","key":"10.1016\/j.hfc.2006.05.002_bib90","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005344-199312001-00002","article-title":"Early structural changes in hypertension: pathophysiology and clinical consequences","volume":"22","author":"Folkow","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.hfc.2006.05.002_bib91","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1152\/ajplegacy.1973.225.5.1226","article-title":"Effects of angiotensin I and angiotensin II on hindlimb and coronary vascular resistance","volume":"225","author":"Britton","year":"1973","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.hfc.2006.05.002_bib92","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1476-5381.1969.tb08015.x","article-title":"Modification of the vasoconstrictor action of sympathomimetic agents by bretylium tosylate and tranylcypromine in man","volume":"36","author":"Frewin","year":"1969","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.hfc.2006.05.002_bib93","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0735-1097(01)01511-X","article-title":"Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis","volume":"38","author":"Prasad","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib94","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/clc.4960270406","article-title":"Dynamic 123I-BMIPP single-photon emission computed tomography in patients with congestive heart failure: effect of angiotensin II type-1 receptor blockade","volume":"27","author":"Takeishi","year":"2004","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib95","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2006.05.002_bib96","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/01.HYP.26.1.124","article-title":"Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients","volume":"26","author":"Weir","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.hfc.2006.05.002_bib97","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM200105033441802","article-title":"Lesser response to angiotensin-converting enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction","volume":"344","author":"Exner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2006.05.002_bib98","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0735-1097(03)00262-6","article-title":"Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials","volume":"41","author":"Shekelle","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib99","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.CIR.101.8.844","article-title":"Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure","volume":"101","author":"Jorde","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/01.RES.0000084993.90444.6C","article-title":"Do studies with ACE N- and C-domain-selective inhibitors provide evidence for a non-ACE, non-chymase angiotensin II-forming pathway?","volume":"93","author":"Husain","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2006.05.002_bib101","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/hrt.82.1.57","article-title":"How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?","volume":"82","author":"MacFayden","year":"1999","journal-title":"Heart"},{"issue":"Supp 2","key":"10.1016\/j.hfc.2006.05.002_bib102","first-page":"S366","article-title":"Evidence for disparate distribution of mast cell chymase and angiotensin converting enzyme in peri-infarct and non-infarct myocardium in ischemic cardiomyopathy","volume":"51","author":"Shirani","year":"2003","journal-title":"J Invest Med"},{"key":"10.1016\/j.hfc.2006.05.002_bib103","doi-asserted-by":"crossref","first-page":"427A","DOI":"10.1016\/S0735-1097(03)81276-7","article-title":"Scintigraphic and immunohistochemical evidence for localization of angiotensin converting enzyme to myocytes in human ischemic cardiomyopathy","volume":"41","author":"Dilsizian","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2006.05.002_bib104","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/01.CIR.94.4.690","article-title":"Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators","volume":"94","author":"Benedict","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib105","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0735-1097(94)90001-9","article-title":"Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril","volume":"24","author":"Rouleau","year":"1994","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2006.05.002_bib106","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1159\/000177418","article-title":"Early administration of ramipril in acute myocardial infarction: neurohormonal and hemodynamic effects and tolerability","volume":"88","author":"van der Ent","year":"1997","journal-title":"Cardiology"},{"key":"10.1016\/j.hfc.2006.05.002_bib107","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0735-1097(01)01714-4","article-title":"Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure","volume":"39","author":"Wilson Tang","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib108","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/01.CIR.92.6.1387","article-title":"Angiotensin-converting enzyme in the human heart: effect of the deletion\/insertion polymorphism","volume":"92","author":"Danser","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib109","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1161\/01.CIR.98.20.2148","article-title":"ACE (I\/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans","volume":"98","author":"Ueda","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib110","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/S0735-1097(01)01237-2","article-title":"Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype","volume":"37","author":"Cicoira","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib111","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/01.CIR.102.8.829","article-title":"Angiotensin-converting enzyme insertion\/deletion polymorphism modulates the human in vivo metabolism of bradykinin","volume":"102","author":"Murphey","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib112","first-page":"1602","article-title":"Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin-converting enzyme inhibition","volume":"13","author":"Hingorani","year":"1995","journal-title":"J Hypertens"},{"key":"10.1016\/j.hfc.2006.05.002_bib113","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00004872-199205000-00011","article-title":"Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corner approach to the identification of genetic determinants of blood pressure","volume":"10","author":"Watt","year":"1992","journal-title":"J Hypertens"},{"key":"10.1016\/j.hfc.2006.05.002_bib114","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0895-7061(02)03063-7","article-title":"Angiotensin II type I receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity and cardiovascular events","volume":"15","author":"Hindorff","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.hfc.2006.05.002_bib115","doi-asserted-by":"crossref","first-page":"E357","DOI":"10.1152\/ajpendo.2000.278.3.E357","article-title":"The angiotensin II type 2 receptor: an enigma with multiple variations","volume":"278","author":"Gallinat","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.hfc.2006.05.002_bib116","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.RES.0000119321.18573.5A","article-title":"Seeing within: molecular imaging of the cardiovascular system","volume":"94","author":"Jaffer","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2006.05.002_bib117","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1152\/jappl.1995.78.3.1158","article-title":"In vivo measurements of pulmonary angiotensin-converting enzyme kinetics. I. Theory and error analysis","volume":"78","author":"Markham","year":"1995","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib118","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/jappl.1995.78.3.1169","article-title":"In vivo measurements of pulmonary angiotensin-converting enzyme kinetics. II. Implementation and application","volume":"78","author":"Schuster","year":"1995","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.hfc.2006.05.002_bib119","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00005344-199110000-00002","article-title":"Angiotensin converting enzyme inhibitor in heart, kidney, and serum studied ex vivo after administration of zofenopril, captopril, and lisonopril","volume":"18","author":"Sun","year":"1991","journal-title":"J Cardiovasc Pharamcol"},{"key":"10.1016\/j.hfc.2006.05.002_bib120","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/ajh\/2.4.294","article-title":"Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs","volume":"2","author":"Cushman","year":"1989","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.hfc.2006.05.002_bib121","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nsb0303-155","article-title":"An ACE structure","volume":"10","author":"Hooper","year":"2003","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.hfc.2006.05.002_bib122","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1089\/152091502760306616","article-title":"From pharmacogenomics to improved patient outcomes: angiotensin I-converting enzyme as an example","volume":"4","author":"Moskowitz","year":"2002","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.hfc.2006.05.002_bib123","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0306-4522(87)90114-X","article-title":"Angiotensin converting enzyme in rat brain visualized by quantitative in vitro autoradiography","volume":"20","author":"Chai","year":"1987","journal-title":"Neuroscience"},{"key":"10.1016\/j.hfc.2006.05.002_bib124","doi-asserted-by":"crossref","first-page":"S268","DOI":"10.1002\/jlcr.2580440194","article-title":"Synthesis of 4-[18F]fluorobenzoyllisinopril: a radioligand for angiotensin converting enzyme (ACE) imaging with positron emission tomography","volume":"44","author":"Lee","year":"2001","journal-title":"J Labelled Comp Radiopharm"},{"key":"10.1016\/j.hfc.2006.05.002_bib125","first-page":"II-694","article-title":"Specific binding of [18F] fluorobenzoyl-lisinopril to angiotensin converting enzyme in human heart tissue of ischemic cardiomyopathy [abstract]","volume":"104","author":"Dilsizian","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2006.05.002_bib126","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jlcr.2580360804","article-title":"Carbon-11 labeling of the potent nonpeptide angiotensin-II antagonist MK-996","volume":"36","author":"Mathews","year":"1995","journal-title":"J Labelled Comp Radiopharm"},{"key":"10.1016\/j.hfc.2006.05.002_bib127","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0969-8043(95)00273-1","article-title":"Development of [11C] L-159,884: a radiolabelled, nonpeptide angiotensin II antagonist that is useful for angiotensin II, AT1 receptor imaging","volume":"47","author":"Hamill","year":"1996","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.hfc.2006.05.002_bib128","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1681\/ASN.V1271350","article-title":"Use of positron emission tomography to study AT1 receptor regulation in vivo","volume":"12","author":"Szabo","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.hfc.2006.05.002_bib129","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00005344-199903000-00004","article-title":"Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist","volume":"33","author":"Lee","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.hfc.2006.05.002_bib130","unstructured":"Verjans J., Lovhaug D., Narula N., et al. Noninvasive imaging of myocardial angiotensin receptors in heart failure. 25th Annual Scientific Sessions, American Heart Association, Western States Affiliates. Irvine (CA), September 30, 2005"},{"key":"10.1016\/j.hfc.2006.05.002_bib131","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1161\/CIRCULATIONAHA.105.167586","volume":"112","author":"Hunt","year":"2005","journal-title":"Circulation"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713606000365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713606000365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T13:37:50Z","timestamp":1628343470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713606000365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":131,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S1551713606000365"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2006.05.002","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}